Sociedad Americana de Hirudoterapia

Effect of different application duration of a venous foot pump on prevention of venous thromboembolism after hip and knee arthroplasty: a multicenter prospective clinical trial

Randomized controlled trial published in BMC musculoskeletal disorders (2023)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Randomized controlled trialEnsayos clínicosGu S et al. · BMC musculoskeletal disorders, 2023

Abstract

OBJECTIVE: To investigate the optimal duration of applying a venous foot pump (VFP) in the prevention of venous thromboembolism (VTE) following hip and knee arthroplasty. METHODS: A total of 230 patients undergoing hip and knee arthroplasty between March 2021 and March 2022 in orthopaedic departments of four major teaching hospitals were prospectively enrolled. Patients were randomly divided into five groups based on the duration of the VFP application. Postoperative deep vein thromboses (DVT), including proximal, distal, and intermuscular DVT, were recorded for analysis. Postoperative blood coagulation examinations, such as D-dimer and active partial thromboplastin time (APTT), pain outcome, and degree of comfort were also collected. RESULTS: Two of the 230 patients withdrew due to early discharge from the hospital, and 228 patients were included in the final analysis. The mean age was 60.38 ± 13.33 years. The baseline characteristics were comparable among the five groups. Compared with the other groups, patients treated with 6-hour VFP had the lowest incidence of DVT (8.7%, 4/46), followed by those treated with 1-hour VFP (15.2%, 7/46), 12-hour VFP (15.6%, 7/45), 18-hour VFP(17.8%, 8/45) and 20-hour VFP(21.7%, 10/46), but with no significant difference (P = 0.539). Regarding postoperative blood coagulation examinations, patients treated with 6-hour VFP had the lowest D-dimer (P = 0.658) and the highest APTT (P = 0.262) compared with the other four groups. 6-hour VFP also had the lowest pain score (P = 0.206) and the highest comfort score (P = 0.288) compared with the other four groups. CONCLUSIONS: Six hours may be the optimal duration of applying VFP for the prevention of VTE in patients undergoing hip and knee arthroplasty in terms of VTE incidence, postoperative blood coagulation examinations, pain outcomes, and comfort scores.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeRandomized Controlled TrialMulticenter StudyJournal Article
Indexed MeSH termsHumansMiddle AgedAgedVenous ThromboembolismProspective StudiesArthroplasty, Replacement, KneeVenous ThrombosisPostoperative ComplicationsPainArthroplasty, Replacement, HipAnticoagulants

Resumen

To investigate the optimal duration of applying a venous foot pump (VFP) in the prevention of venous thromboembolism (VTE) following hip and knee arthroplasty. A total of 230 patients undergoing hip and knee arthroplasty between March 2021 and March 2022 in orthopaedic departments of four major teaching hospitals were prospectively enrolled.

Por qué esto importa para la hirudoterapia

Este ensayo clínico aleatorizado multicéntrico asignó a 228 pacientes de artroplastia de cadera y rodilla a cinco duraciones de una bomba venosa mecánica para el pie y encontró que una aplicación de 6 horas tuvo la incidencia más baja de trombosis venosa profunda (8.7%) junto con tendencias favorables de D-dímero, comodidad y dolor, aunque las diferencias entre las duraciones no fueron estadísticamente significativas. La relevancia para ASH es indirecta y contextual: aborda la prevención de la tromboembolia venosa posquirúrgica y la estasis venosa, el mismo territorio clínico donde a veces se discute la aplicación localizada de sanguijuelas para aliviar la congestión venosa. Advertencia honesta: este ensayo estudia un dispositivo de compresión mecánica, no terapia anticoagulante ni hirudoterapia, las diferencias entre los grupos no fueron significativas, y nada en el resumen tiene relación con el secretoma de la sanguijuela medicinal ni con el tratamiento con sanguijuelas en sí.

Citación

Effect of different application duration of a venous foot pump on prevention of venous thromboembolism after hip and knee arthroplasty: a multicenter prospective clinical trial.

Gu S et al. · BMC musculoskeletal disorders, 2023

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 28, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.